Table 3 Availability of essential antidotes at selected primary and secondary health care institutions of Anuradhapura, 2016
Antidote | Institutions | |||||
|---|---|---|---|---|---|---|
BH | DH | PU | RH | CD-1 | CD-2 | |
Non-specific antidotes | ||||||
 Charcoal (Activated) | P | P | P | P | A | A |
 Fuller’s earth | A | P | P | A | A | A |
Specific antidotes | ||||||
 Acetylcysteine | P | NA | NA | NA | NA | NA |
 Atropine | P | P | P | P | P | A |
 Flumazenil | P | NA | NA | NA | NA | NA |
 DL-methionine | P | A | A | A | A | A |
 Naloxone | P | A | A | A | A | A |
 Pralidoxime | P | NA | NA | NA | NA | NA |